Amyloidosis Cardiac Clinical Trials

11 recruiting

Amyloidosis Cardiac Trials at a Glance

11 actively recruiting trials for amyloidosis cardiac are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Essen, Cleveland, and Dallas. Lead sponsors running amyloidosis cardiac studies include University Hospital, Essen, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Dominik Benz.

Browse amyloidosis cardiac trials by phase

Treatments under study

About Amyloidosis Cardiac Clinical Trials

Looking for clinical trials for Amyloidosis Cardiac? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Amyloidosis Cardiac trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Amyloidosis Cardiac clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

AmyloidosisAmyloidosis CardiacATTR Amyloidosis Wild Type
Paolo Milani200 enrolled1 locationNCT06251778
Recruiting

BE.Amycon Biobank & Data Registry UZ Leuven

AmyloidosisAL AmyloidosisAmyloidosis Cardiac
Universitaire Ziekenhuizen KU Leuven505 enrolled2 locationsNCT07172243
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

Amyloidosis CardiacAmyloidosis, HereditaryWild-type ATTR Amyloidosis+1 more
University of Sao Paulo General Hospital70 enrolled1 locationNCT07314268
Recruiting
Not Applicable

Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

Amyloidosis Cardiac
Dominik Benz50 enrolled1 locationNCT07112066
Recruiting
Phase 4

Ultrasound Therapy In Cardiac Amyloidosis

Amyloidosis Cardiac
Brigham and Women's Hospital70 enrolled1 locationNCT04667494
Recruiting

Essen Amyloidosis Registry

Amyloidosis CardiacAmyloidosis; Systemic
University Hospital, Essen400 enrolled1 locationNCT06887283
Recruiting

Intracardiac Flow Assessment in Cardiac Amyloidosis

Healthy AdultsAmyloidosis Cardiac
Mayo Clinic100 enrolled1 locationNCT05379101
Recruiting

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Amyloidosis CardiacAmyloidosis, HereditaryAmyloidosis, Familial+2 more
University of Texas Southwestern Medical Center500 enrolled3 locationsNCT05489549
Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Sudden Cardiac Death+14 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna700 enrolled3 locationsNCT06813443
Recruiting

Cardiac Amyloidosis in HFpEF

Heart Failure With Preserved Ejection FractionAmyloidosis Cardiac
National Taiwan University Hospital250 enrolled1 locationNCT04587648